KIMS releases audio recording of Q2 FY26 analyst/investor conference call
KIMS announces the availability of the audio recording for its Q2 FY26 conference call with investors and analysts, held on November 10, 2025, on its website.
The release of an audio recording for a past conference call is a routine compliance activity and does not contain new material information that would significantly impact the company's valuation or investor sentiment.
The announcement is a standard disclosure regarding the availability of the audio recording for a past conference call, indicating transparency without revealing new financial or operational information.
Krishna Institute of Medical Sciences Limited (KIMS) announced the availability of the audio recording for its conference call with investors and analysts concerning Q2 FY26 financial results. The conference call took place on November 10, 2025. The audio recording is accessible on the company's website at https://www.kimshospitals.com/investors under the 'Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015' section, specifically within 'Analysts Calls schedule, PPT & Transcripts > Transcripts, Audio & Video Recordings > FY 25-26'.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.